KLK3 and posterior cortical atrophy: The German “Prostate Cancer Early Detection Study Based on a Baseline PSA Value in Young Men” (PROBASE) is an ongoing randomized clinical trial that investigates risk-adapted PCa screening starting at either 45 or 50 years old [6].